The Dexcom developer guide distinguishes sandbox testing, limited access, and reviewed full access. A Dexcom CGM integration should not present a sandbox response as proof that it may retrieve any user's health data.
Build consent revocation and unavailable-data states into the interface. Confirm the authorized product's intended use before relying on returned measurements for any real-time or treatment-related decision.
Akousa